ULTRAPROCT, suppository 10 suppositories
Active ingredients: Dibucaine hydrochloride, Fluocortolone caproate, Fluocortolone pivalate
Commercialized according to BDPMDispensing in France: Prescription only
Suppository10 suppositoriesrectale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ULTRAPROCT, suppositoire
- Pharmaceutical form
- suppositoire
- Route of administration
- rectale
- Presentation description
- plaquette(s) thermoformée(s) aluminium polyéthylène de 10 suppositoire(s)
- Marketing authorisation holder
- KARO PHARMA (SUEDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 19 Jan 1970
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63394747CIP73110143CIP133400931101437Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FLUOCORTOLONE (CAPROATE DE)suppositoire | 0,630 mg · un suppositoire | SA |
| CINCHOCAÏNE (CHLORHYDRATE DE)suppositoire | 1,000 mg · un suppositoire | SA |
| FLUOCORTOLONE (PIVALATE DE)suppositoire | 0,612 mg · un suppositoire | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.